Clinical trial
Aripiprazole in Children and Adolescents With Bipolar Disorder and Attention…
NCT00116259 · Federal University of Rio Grande do Sul, Other · Completed
Key facts
| NCT number | NCT00116259 |
|---|---|
| Title | Aripiprazole in Children and Adolescents With Bipolar Disorder and Attention Deficit Hyperactivity Disorder (ADHD) |
| Official title | Aripiprazole in Children and Adolescents With Bipolar Disorder and ADHD: A Randomized Double Blind Placebo Controlled Trial |
| Lead sponsor | Federal University of Rio Grande do Sul, Other |
| Collaborators | Hospital de Clinicas de Porto Alegre |
| Status | Completed |
| Study type | Interventional |
| Conditions | Bipolar Disorder, Attention Deficit Hyperactivity Disorder |
| Intervention type | Drug |
| Interventions | Aripiprazole |
| Enrollment | 50 |
| Start date | Mar 1, 2005 |
| Primary completion | Jan 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Jun 28, 2005 |
| Last update posted | Aug 7, 2008 |
| Countries | Brazil |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: